Pharmacological management of borderline personality disorder and common comorbidities
JC Pascual, L Arias, J Soler - CNS drugs, 2023 - Springer
Comorbidity between borderline personality disorder (BPD) and other mental disorders is
common. Although no specific pharmacological treatments have been approved for the …
common. Although no specific pharmacological treatments have been approved for the …
How can the DSM-5 alternative model of personality disorders advance understanding of depression?
Background The DSM-5 introduced an alternative model of personality disorder (AMPD) that
includes personality dysfunction plus maladaptive-range traits. This study clarifies relations …
includes personality dysfunction plus maladaptive-range traits. This study clarifies relations …
Does the comorbidity of borderline personality disorder affect the response to treatment in bipolar patients?
CM Esposito, JL Barkin, A Ceresa… - International Clinical …, 2024 - journals.lww.com
Bipolar disorder (BD) is a highly prevalent condition whose response to pharmacological
treatment is associated with a number of factors including psychiatric comorbidity. Borderline …
treatment is associated with a number of factors including psychiatric comorbidity. Borderline …
Nonremission after electroconvulsive therapy in individuals with major depression: role of borderline personality disorder
Objectives The aim of the present study was to investigate the risk of nonremission following
electroconvulsive therapy (ECT), as associated with borderline personality disorder, in …
electroconvulsive therapy (ECT), as associated with borderline personality disorder, in …
[HTML][HTML] Bipolar disorder predicted shorter and borderline personality disorder symptoms longer time to remission–a prospective cohort study of major depressive …
JJ Söderholm, JL Socada, T Rosenström… - Journal of Affective …, 2022 - Elsevier
Abstract Background Major depressive episodes (MDEs) of major depressive (MDD) or
bipolar disorders (BD) are frequently complicated by features of borderline personality …
bipolar disorders (BD) are frequently complicated by features of borderline personality …
The effect of IV ketamine in patients with major depressive disorder and elevated features of borderline personality disorder
KS Chen, Y Dwivedi, RC Shelton - Journal of Affective Disorders, 2022 - Elsevier
Background Comorbid borderline personality disorder and major depressive disorder is
common and often not adequately responsive to standard antidepressant therapies …
common and often not adequately responsive to standard antidepressant therapies …
The role of borderline personality disorder traits in predicting longitudinal variability of major depressive symptoms among a sample of depressed adults
Background Major depressive disorder (MDD) and borderline personality disorder (BPD)
often co-occur, with 20% of adults with MDD meeting criteria for BPD. While MDD is typically …
often co-occur, with 20% of adults with MDD meeting criteria for BPD. While MDD is typically …
Depression with comorbid borderline personality disorder-could ketamine be a treatment catalyst?
M Więdłocha, P Marcinowicz, J Komarnicki… - Frontiers in …, 2024 - frontiersin.org
Borderline personality disorder (BPD) is diagnosed in 10-30% of patients with major
depressive disorder (MDD), and the frequency of MDD among individuals with BPD reaches …
depressive disorder (MDD), and the frequency of MDD among individuals with BPD reaches …
Prefrontal cortex engagement during an fMRI task of emotion regulation as a potential predictor of treatment response in borderline personality disorder
Background Borderline personality disorder (BPD) is a severe mental illness, with high rates
of co-morbid depression and suicidality. Despite the importance of optimizing treatment in …
of co-morbid depression and suicidality. Despite the importance of optimizing treatment in …
Intranasal oxytocin as an adjunct treatment among patients with severe major depression with and without comorbid borderline personality disorder
H Maoz, A Grossman-Giron, O Sedoff, U Nitzan… - Journal of Affective …, 2024 - Elsevier
Introduction Results of studies concerning a possible beneficial effect of Intranasal-Oxytocin
(IN-OT) as an add-on treatment for patients with major depression (MDD) have been …
(IN-OT) as an add-on treatment for patients with major depression (MDD) have been …